{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T06:12:29Z","timestamp":1740118349455,"version":"3.37.3"},"reference-count":9,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["1296723N","G0A0522N"],"award-info":[{"award-number":["1296723N","G0A0522N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","bmn.com","cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Parasitology"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.pt.2024.06.005","type":"journal-article","created":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T15:48:42Z","timestamp":1721922522000},"page":"667-669","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Doxycycline, a role in the treatment of onchocerciasis-associated epilepsy?"],"prefix":"10.1016","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2190-4562","authenticated-orcid":false,"given":"Elisa","family":"Pierella","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3544-1239","authenticated-orcid":false,"given":"Joseph Nelson","family":"Siewe Fodjo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1919-1340","authenticated-orcid":false,"given":"Robert","family":"Colebunders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pt.2024.06.005_bb0005","doi-asserted-by":"crossref","first-page":"E1149","DOI":"10.1016\/S2214-109X(24)00102-5","article-title":"Doxycycline for the treatment of nodding syndrome: a randomised, placebo-controlled, phase 2 trial","volume":"12","author":"Idro","year":"2024","journal-title":"Lancet Glob. Health"},{"key":"10.1016\/j.pt.2024.06.005_bb0010","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.pt.2022.11.010","article-title":"Onchocerciasis-associated epilepsy: an update and future perspectives","volume":"39","author":"Hadermann","year":"2023","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.pt.2024.06.005_bb0015","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1684\/epd.2020.1164","article-title":"Persons with onchocerciasis-associated epilepsy and nodding seizures have a more severe form of epilepsy with more cognitive impairment and higher levels of Onchocerca volvulus infection","volume":"22","author":"Abd-Elfarag","year":"2020","journal-title":"Epileptic Disord."},{"key":"10.1016\/j.pt.2024.06.005_bb0020","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40249-020-0628-3","article-title":"Prevalence and incidence of nodding syndrome and other forms of epilepsy in onchocerciasis-endemic areas in northern Uganda after the implementation of onchocerciasis control measures","volume":"9","author":"Gumisiriza","year":"2020","journal-title":"Infect. Dis. Poverty"},{"key":"10.1016\/j.pt.2024.06.005_bb0025","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.seizure.2018.11.004","article-title":"High prevalence of onchocerciasis-associated epilepsy in villages in Maridi County, Republic of South Sudan: a community-based survey","volume":"63","author":"Colebunders","year":"2018","journal-title":"Seizure \u2013 Eur. J. Epilep."},{"key":"10.1016\/j.pt.2024.06.005_bb0030","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/S1473-3099(20)30122-5","article-title":"Changes in epilepsy burden after onchocerciasis elimination in a hyperendemic focus of western Uganda: a comparison of two population-based, cross-sectional studies","volume":"20","author":"Gumisiriza","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.pt.2024.06.005_bb0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0011523","article-title":"The onchocerciasis hypothesis of nodding syndrome","volume":"17","author":"Colebunders","year":"2023","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.pt.2024.06.005_bb0040","article-title":"The RNA virome of human and animal parasitic nematodes","author":"Quek","year":"2023","journal-title":"Res. Sq."},{"key":"10.1016\/j.pt.2024.06.005_bb0045","doi-asserted-by":"crossref","first-page":"5064","DOI":"10.3390\/molecules25215064","article-title":"In vitro antiviral activity of doxycycline against SARS-CoV-2","volume":"25","author":"Gendrot","year":"2020","journal-title":"Molecules"}],"container-title":["Trends in Parasitology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471492224001636?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471492224001636?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,5]],"date-time":"2024-10-05T03:22:10Z","timestamp":1728098530000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471492224001636"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":9,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S1471492224001636"],"URL":"https:\/\/doi.org\/10.1016\/j.pt.2024.06.005","relation":{},"ISSN":["1471-4922"],"issn-type":[{"type":"print","value":"1471-4922"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Doxycycline, a role in the treatment of onchocerciasis-associated epilepsy?","name":"articletitle","label":"Article Title"},{"value":"Trends in Parasitology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pt.2024.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2214-109X(24)00102-5","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}